Viva Biotech Holdings (HKG: 1873)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.600
-0.020 (-3.23%)
Sep 10, 2024, 3:59 PM HKT

Viva Biotech Holdings Company Description

Viva Biotech Holdings, an investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.

The company provides discovery biology services, including protein expression and purification, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacokinetics; chemistry services, such as medicinal and synthetic chemistry, analytical chemistry, purification preparation, and computer-aided drug design services, as well as offers chemical technology platforms; and antibody/biologics research and development services comprising recombinant protein expression platform, antibody discovery and affinity maturation, assay platform, antibody production and identification platform, and antigen-antibody structural resolution platform solutions.

It also offers PROTAC/molecular glue services, including protein preparation and ternary complex structure determination, screening for molecule glues and novel E3 ligase ligands, PROTAC ternary complex kinetics, PROTAC degradation assays and ternary complex assays, PROTAC molecule design and synthesis, ADME & PK/PD studies of PROTAC molecules, and computer aided PROTAC design solutions; and XDC platforms, such as XDC conjugation and quality study, XDC chemistry research and development, and XDC functional studies.

In addition, the company offers contract development and manufacturing services comprising integrated services for small molecule active pharmaceutical ingredients, formulation development and production services, and pharmaceutical analysis services, as well as CMC filing, global filing registration support, and other services.

Further, it provides laboratory rental, and project management and bidding services, as well as sells compounds.

The company was incorporated in 2008 and is headquartered in Shanghai, China.

Viva Biotech Holdings
Country Cayman Islands
Founded 2008
Industry Biotechnology
Sector Healthcare
Employees 2,077
CEO Chen Cheney Mao

Contact Details

Address:
No.735, Ziping Road
Shanghai, 201318
China
Phone 86 21 6089 3288
Website vivabiotech.com.cn

Stock Details

Ticker Symbol 1873
Exchange Hong Kong Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number KYG9390W1015
SIC Code 8731

Key Executives

Name Position
Dr. Chen Cheney Mao Ph.D. Chairman and Chief Executive Officer
Ying Wu M.B.A. Executive Vice President and Executive Director
Dr. Delin Ren Ph.D. Executive Director
Zheren Wang C.F.A. Co-Chief Financial Officer
Wei Xiong Co-Chief Financial Officer
Xueheng Cheng Ph.D. Chief Technology Officer
Dr. Zhixiong Ye Ph.D. Chief Scientific Officer
Han Dai Ph.D. Chief Innovation Officer and Head of Viva BioInnovator
Jianhua Cai Ph.D. Senior Vice President
Jianguo Ma Ph.D. Senior Vice President and President of Shanghai Langhua Pharmaceutical